Dr Reddy's Laboratories Operating Income 2010-2024 | RDY
Dr Reddy's Laboratories annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Dr Reddy's Laboratories operating income for the quarter ending September 30, 2024 was $0.209B, a 2.88% decline year-over-year.
- Dr Reddy's Laboratories operating income for the twelve months ending September 30, 2024 was $0.806B, a 4.72% increase year-over-year.
- Dr Reddy's Laboratories annual operating income for 2024 was $0.812B, a 16.83% increase from 2023.
- Dr Reddy's Laboratories annual operating income for 2023 was $0.695B, a 78.66% increase from 2022.
- Dr Reddy's Laboratories annual operating income for 2022 was $0.389B, a 13.36% decline from 2021.
Dr Reddy's Laboratories Annual Operating Income
(Millions of US $) |
| 2024 |
$812 |
| 2023 |
$695 |
| 2022 |
$389 |
| 2021 |
$449 |
| 2020 |
$435 |
| 2019 |
$302 |
| 2018 |
$183 |
| 2017 |
$208 |
| 2016 |
$447 |
| 2015 |
$422 |
| 2014 |
$435 |
| 2013 |
$355 |
| 2012 |
$365 |
| 2011 |
$258 |
| 2010 |
$223 |
| 2009 |
$-79 |
Dr Reddy's Laboratories Quarterly Operating Income
(Millions of US $) |
| 2024-09-30 |
$209 |
| 2024-06-30 |
$215 |
| 2024-03-31 |
$175 |
| 2023-12-31 |
$207 |
| 2023-09-30 |
$215 |
| 2023-06-30 |
$215 |
| 2023-03-31 |
$139 |
| 2022-12-31 |
$200 |
| 2022-09-30 |
$202 |
| 2022-06-30 |
$154 |
| 2022-03-31 |
$11 |
| 2021-12-31 |
$125 |
| 2021-09-30 |
$164 |
| 2021-06-30 |
$90 |
| 2021-03-31 |
$106 |
| 2020-12-31 |
$112 |
| 2020-09-30 |
$123 |
| 2020-06-30 |
$108 |
| 2020-03-31 |
$112 |
| 2019-12-31 |
$103 |
| 2019-09-30 |
$104 |
| 2019-06-30 |
$116 |
| 2019-03-31 |
$82 |
| 2018-12-31 |
$80 |
| 2018-09-30 |
$72 |
| 2018-06-30 |
$68 |
| 2018-03-31 |
$40 |
| 2017-12-31 |
$78 |
| 2017-09-30 |
$59 |
| 2017-06-30 |
$6 |
| 2017-03-31 |
$55 |
| 2016-12-31 |
$85 |
| 2016-09-30 |
$51 |
| 2016-06-30 |
$17 |
| 2016-03-31 |
$68 |
| 2015-12-31 |
$115 |
| 2015-09-30 |
$143 |
| 2015-06-30 |
$121 |
| 2015-03-31 |
$132 |
| 2014-12-31 |
$115 |
| 2014-09-30 |
$89 |
| 2014-06-30 |
$104 |
| 2014-03-31 |
$88 |
| 2013-12-31 |
$129 |
| 2013-09-30 |
$118 |
| 2013-06-30 |
$63 |
| 2013-03-31 |
$100 |
| 2012-12-31 |
$75 |
| 2012-09-30 |
$113 |
| 2012-06-30 |
$70 |
| 2012-03-31 |
$163 |
| 2011-12-31 |
$142 |
| 2011-09-30 |
$43 |
| 2011-06-30 |
$66 |
| 2011-03-31 |
$39 |
| 2010-12-31 |
$62 |
| 2010-09-30 |
$87 |
| 2010-06-30 |
$53 |
| 2010-03-31 |
$-17 |
| 2009-12-31 |
$55 |
| 2009-09-30 |
$54 |
| 2009-06-30 |
$69 |
| 2009-03-31 |
$188 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$12.621B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
